Equity
Total Liabilities & Equity
ResMed Total Liabilities & Equity increased by 3.3% to $8.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $7.57B to $8.78B. Over 4 years (FY 2021 to FY 2025), Total Liabilities & Equity shows an upward trend with a 14.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase typically reflects overall balance sheet growth or expansion of the company's asset base, while a decrease may indicate divestitures or debt repayment.
Detailed definition
This represents the sum of all claims against a company's assets, combining obligations to external creditors and the re...
Peer comparison
This is a standard accounting identity used across all industries to verify that assets equal the sum of liabilities and equity.
Metric ID:
total_liabilities_and_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.73B | $4.73B | $4.73B | $4.91B | $5.10B | $5.18B | $6.68B | $6.71B | $6.75B | $6.74B | $6.91B | $6.81B | $6.87B | $7.22B | $7.14B | $7.57B | $8.17B | $8.31B | $8.50B | $8.78B |
| QoQ Change | — | +0.0% | +0.1% | +3.6% | +3.9% | +1.6% | +28.9% | +0.6% | +0.6% | -0.2% | +2.4% | -1.3% | +0.8% | +5.1% | -1.1% | +6.0% | +8.0% | +1.6% | +2.3% | +3.3% |
| YoY Change | — | — | — | — | +7.8% | +9.5% | +41.0% | +36.9% | +32.5% | +30.2% | +3.4% | +1.5% | +1.8% | +7.1% | +3.4% | +11.0% | +18.9% | +15.0% | +19.1% | +16.1% |
Range$4.73B – $8.78B
CAGR+13.9%
Avg YoY Growth+16.0%
Median YoY Growth+13.0%
Current Streak5 quarters growth
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is ResMed's total liabilities & equity?
- ResMed (RMD) reported total liabilities & equity of $8.78B in Q1 2026.
- How has ResMed's total liabilities & equity changed year-over-year?
- ResMed's total liabilities & equity increased by 16.1% year-over-year, from $7.57B to $8.78B.
- What is the long-term trend for ResMed's total liabilities & equity?
- Over 4 years (2021 to 2025), ResMed's total liabilities & equity has grown at a 14.7% compound annual growth rate (CAGR), from $4.73B to $8.17B.
- What does total liabilities & equity mean?
- The total amount of money a company owes to others plus the value owned by its shareholders.